Two U.S. lawmakers are questioning whether drugmaker Mylan overcharged Medicaid for its EpiPen device, reports Reuters. Sen. Ron Wyden (D-Ore.) and Rep. Frank Pallone (D-N.J.) are calling for an ...

Mylan and federal investigators Thursday finalized a $465 million settlement of charges the drugmaker overcharged the government for the injection allergy medication EpiPen. Resolving an issue that ...

WASHINGTON — Despite a withering 4-plus hours of questioning by members of a congressional committee yesterday, Mylan CEO Heather Bresch did not give a direct answer as to why the company had ...

NEW YORK (WABC) -- New York's attorney general announced Monday his office has launched an antitrust investigation into the maker of the EpiPen. "A preliminary review by the Office of the Attorney ...

Mylan faces an increasing backlash over it handling of the EpiPen pricing controversy, as a top proxy adviser urged shareholders to oust the drugmaker’s board. Institutional Shareholder Services said ...

On January 16, Attorney General (AG) Jason Miyares’s last day in office, the Virginia AG reached a settlement with Viatris, Mylan’s corporate successor, over EpiPen pricing and related practices. The ...

Amid the firestorm of controversy surrounding drug maker Mylan’s decision to hike up prices for the life-saving EpiPen, actress Sarah Jessica Parker has ended her relationship with the company.

FILE - In this July 8, 2016, file photo, a pharmacist holds a package of EpiPens epinephrine auto-injector, a Mylan product, in Sacramento, Calif. Mylan said it will make available a generic version ...